GCO:NYSEGenesco Inc. Analysis
Data as of 2026-06-21 - not real-time
$35.67
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Genesco's stock is trading below its 20‑day and 50‑day simple moving averages, indicating short‑term weakness, while the broader trend remains bullish according to the computed trend direction. The RSI sits in a neutral zone, suggesting neither overbought nor oversold conditions, and the MACD has turned bearish, hinting at potential downward pressure in the near term. However, the DCF fair value is substantially higher than the current market price, pointing to a notable undervaluation and an upside opportunity. The company’s price‑to‑book ratio is well below one, reinforcing the value case, and the absence of a dividend eliminates yield concerns. High beta and a 30‑day volatility exceeding sixty percent signal a volatile equity that can swing sharply on market sentiment.
Fundamentally, Genesco shows modest revenue growth and a solid gross margin, yet its operating margin remains negative and return on equity is low, reflecting profitability challenges. The balance sheet carries a high debt load relative to equity, though cash flow from operations is positive, providing some cushion. The consumer cyclical sector exposure adds sensitivity to discretionary spending trends, while geographic diversification across North America and Europe moderates regional risk. No dividend is paid, so dividend sustainability is not applicable. Overall, the stock presents a value‑oriented entry point for investors comfortable with elevated risk and willing to navigate short‑term technical headwinds.
Fundamentally, Genesco shows modest revenue growth and a solid gross margin, yet its operating margin remains negative and return on equity is low, reflecting profitability challenges. The balance sheet carries a high debt load relative to equity, though cash flow from operations is positive, providing some cushion. The consumer cyclical sector exposure adds sensitivity to discretionary spending trends, while geographic diversification across North America and Europe moderates regional risk. No dividend is paid, so dividend sustainability is not applicable. Overall, the stock presents a value‑oriented entry point for investors comfortable with elevated risk and willing to navigate short‑term technical headwinds.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price below short‑term moving averages
- bearish MACD signal
- high short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF‑derived undervaluation
- low price‑to‑book ratio
- stable operating cash flow
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- persistent operating margin pressure
- high debt‑to‑equity ratio
- exposure to consumer discretionary cycles
Key Metrics & Analysis
Financial Health
Revenue Growth2.80%
Profit Margin0.80%
P/E Ratio19.3
ROE3.66%
ROA1.22%
Debt/Equity104.22
P/B Ratio0.7
Op. Cash Flow$144.0M
Free Cash Flow$79.4M
Technical Analysis
TrendBullish
RSI46.2
Support$32.74
Resistance$43.60
MA 20$38.20
MA 50$35.68
MA 200$30.84
MACDBearish
VolumeStable
Fear & Greed Index91.46
Valuation
Fair Value$56.75
Target Price$40.33
Upside/Downside13.07%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.71
Volatility67.55%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.